Phase 1/2 clinical study of dasatinib in Japanese patients with chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia

• SAKAMAKI Hisashi

  Department of Hematology, Metropolitan Komagome Hospital

• ISHIZAWA Ken-ichi

  Tohoku University

• TANIWAKI Masafumi

  Kyoto Prefectural University of Medicine

• FUJISAWA Shin

  Yokohama City University Medical Center

• MORISHIMA Yasuo

  Aichi Cancer Center

• TOBINAI Kensei

  National Cancer Center

• OKADA Masaya

  Hyogo Medical University

• ANDO Kiyoshi

  Tokai University

• USUI Noriko

  Jikei University School of Medicine

• MIYAWAKI Shuichi

  Saiseikai Maebashi Hospital

• UTSUNOMIYA Atae

  Jiaikai Imamura Hospital Branch Hospital

• UOSHIMA Nobuhiko

  Matsushita Memorial Hospital

• NAGAI Tadashi

  Jichi Medical School

• NAOE Tomoki

  Nagoya University

• MOTOJI Toshiko

  Tokyo Women's Medical University

• JINNAI Itsuro

  Saitama Medical University

• TANIMOTO Mitsune

  Okayama University

• MIYAZAKI Yasushi

  Nagasaki University

• OHNISHI Kazunori

  Hamamatsu University School of Medicine

• IIDA Shinsuke

  Nagoya City University

• OKAMOTO Shinichiro

  Keio University

• SERIU Taku

  Bristol-Myers K.K.

• OHNO Ryuzo

  Aichi Shukutoku University

収録刊行物

• International journal of hematology

  International journal of hematology 89 (3), 332-341, 2009-04-15

キーワード

• CML
• Ph^+ ALL
• Dasatinib
• Imatinib resistant
• Imatinib intolerant

詳細情報

• CRID: 1573105975682566784
• NII論文ID: 10025160810
• NII書誌ID: AA10797094
• ISSN: 09255710
• Web Site: https://search.jamas.or.jp/link/ui/2009307984
• 本文言語コード: en
• データソース種別:
  • CiNii Articles